SCHEMBL6996504

SCHEMBL6996504

O=C1c2ccc(Cl)cc2SCc2cccnc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 10/20 0.51
FNTB P49356 10/20 0.51
EGFR P00533 3/20 0.46
KDR P35968 1/20 0.44
CA12 O43570 3/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA9 Q16790 3/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HRH1 P35367 2/20 0.41
LMNA P02545 1/20 0.41
ADRB2 P07550 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
ABCB1 P08183 1/20 0.41
HTR1A P08908 1/20 0.41
CHRM5 P08912 1/20 0.41
ADRA2A P08913 1/20 0.41
CHRM1 P11229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29413038 0.77 HRH1 (0.60) FNTAFNTBMEN1KMT2AHRH1
SCHEMBL3839936 0.77 HRH1 (0.60) FNTAFNTBMEN1KMT2AHRH1
SCHEMBL6993629 0.77 HRH1 (0.69) FNTAFNTBMEN1KMT2AHRH1
SCHEMBL6996008 0.76 FNTA (0.71) FNTAFNTBHRH1CHRM2HTR1A
SCHEMBL9207035 0.75 FNTA (0.58) FNTAFNTBMEN1KMT2AHRH1
SCHEMBL6998860 0.74 FNTA (0.49) FNTAFNTBMEN1KMT2AHRH1
SCHEMBL9374487 0.74 PTAFR (0.73) FNTAFNTBHRH1PTAFR
SCHEMBL9374136 0.72 FNTA (0.61) FNTAFNTBHRH1PTAFR
SCHEMBL6999299 0.72 FNTA (0.52) FNTAFNTBMEN1KMT2AHRH1
SCHEMBL9563106 0.72 FNTA (0.78) FNTAFNTBHRH1PTAFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021448-B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORP (US) 2003-05-02 EP disclosed
US-6130229-A Tricyclic compounds having activity as RAS-FPT inhibitors SCHERING CORPORATION (US) 2000-10-10 US disclosed
EP-1021448-A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORPORATION (US) 2000-07-26 EP disclosed
WO-1998015556-A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORPORATION (US) 1998-04-16 WO disclosed
EP-0535152-B1 Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylene and piperazine compounds as PAF antagonists and compositions thereof. SCHERING CORP (US) 1995-08-09 EP disclosed
US-5430032-A Treating asthma, allergy, inflammation SCHERING CORPORATION (US) 1995-07-04 US disclosed
US-5422351-A Antiallergens; antiinflammatory agents SCHERING CORPORATION (US) 1995-06-06 US disclosed
EP-0341860-B1 Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use SCHERING CORP (US) 1994-07-13 EP disclosed
EP-0524784-A1 Benzopyrido piperidylidene compounds as PAF antagonists SCHERING CORPORATION (US) 1993-01-27 EP disclosed
US-5104876-A Antiallergens, antiinflammatory agent SCHERING CORPORATION 1992-04-14 US disclosed
EP-0411048-A1 NOVEL BENZOPYRIDO PIPERIDINE, PIPERIDYLIDENE AND PIPERAZINE COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE AND METHODS OF USE SCHERING CORPORATION (US) 1991-02-06 EP disclosed
EP-0341860-A1 Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use SCHERING CORPORATION (US) 1989-11-15 EP disclosed
WO-1989010369-A1 NOVEL BENZOPYRIDO PIPERIDINE, PIPERIDYLIDENE AND PIPERAZINE COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE AND METHODS OF USE SCHERING CORPORATION (US) 1989-11-02 WO disclosed